Onward Medical NV

STU:63E (Netherlands)  
€ 4.76 (-2.06%) May 9
At Loss
P/B:
8.55
Market Cap:
€ 167.60M ($ 180.67M)
Enterprise V:
€ 154.71M ($ 166.77M)
Volume:
-
Avg Vol (2M):
707.00
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
707.00

Business Description

Description
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injuries. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United States and four European markets: Germany, France, the UK, and the Netherlands to create a customer base.
Name Current Vs Industry Vs History
Cash-To-Debt 1.76
Equity-to-Asset 0.41
Debt-to-Equity 0.94
Debt-to-EBITDA -0.5
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 24.3
3-Year EPS without NRI Growth Rate 29.3
3-Year FCF Growth Rate 21.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 49.55
9-Day RSI 45.83
14-Day RSI 46.6
6-1 Month Momentum % 48.98
12-1 Month Momentum % 23.47

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.7
Quick Ratio 4.7
Cash Ratio 4.46
Days Payable 717.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -72.3
Shareholder Yield % -1.3
Name Current Vs Industry Vs History
ROE % -103.54
ROA % -60.55
ROIC % -257.33
ROC (Joel Greenblatt) % -1647.58
ROCE % -66.4